Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Simcere Pharmaceutical Group Limited ( (HK:2096) ).
Simcere Pharmaceutical Group Limited announced an expected revenue increase for FY2024, with profits projected to rise significantly, largely due to growth in their innovative pharmaceutical business. The company anticipates a substantial increase in adjusted profits, signifying a strengthened market position and potential positive implications for stakeholders.
More about Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Limited is a Hong Kong-based company specializing in the pharmaceutical industry, focusing on innovative pharmaceutical products.
YTD Price Performance: 9.15%
Average Trading Volume: 4,099,032
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$18.52B
Learn more about 2096 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue